Abstract. The activation of the insulin-like growth factor 1/IGF1 receptor system (IGF1/IGF1R) is a critical event in the transformation and tumorigenicity processes in a wide variety of human tumors. The IGF1/IGF1R system has been recently studied in carcinoid tumors that often arise in the gastrointestinal tract; these tumors are characterized by hypersecretion of bioamines and neuropeptides, leading to functional tumor disease. Two alternatively spliced IGF1R mRNA transcripts have been described to differ by only three nucleotides (CAG) in the coding sequence, resulting in an amino-acid change from the originally described Thr-Gly to an Arg in the extracellular portion of the receptor ß subunit. In transfected Chinese hamster ovary cells, the form without CAG (CAG -) exhibited an approximate 2-fold increase in IGF1 stimulation of activities required for its mitogenic properties. In this study, we examine the relative expression of the two IGF1R mRNA isoforms by a semiquantitative RT-PCR approach using highly standardized conditions, ß-2 microglobulin (B2M) as a reference gene and gel imaging analysis. We analyzed a large series of human neuroendocrine tumors (32 samples) and 9 normal tissues. A significant higher expression of both isoforms in the tumor samples (~2-fold increase) was found, while a constant CAG + /CAG -IGF1R mRNA isoforms of an approximate 3:1 ratio was observed in all tumoral and normal cell types studied. The phylogenetic study of the IGF1R locus in several species suggests that human IGF1R CAG -mRNA isoform is evolutionarily more recent compared to the IGF1R CAG + mRNA isoform and it could be used by the splicing apparatus at this intron/exon junction with a lower efficiency. This study highlights the relevance of IGF1R mRNA expression in neuroendocrine tumor cells, and the constant presence of 'subtle' alternative splicing for the IGF1R locus.
Introduction
The insulin-like growth factor 1 receptor (IGF1R) gene (1) encodes for a transmembrane receptor with tyrosine kinase activity which binds insulin-like growth factor with a high affinity. In the last decade, IGF1R has emerged as a key regulator of mitogenesis and tumorigenicity, because of its crucial role in cell transformation, tumor invasion, metastasis, and cell survival enhancement due to anti-apoptotic activity (2) . IGF1R is a heterotetramer composed of two extracellular · subunits containing the ligand-binding site and two transmembrane ß subunits harboring intracellular tyrosine kinase activity, connected by disulfide bonds. The activation of the insulin-like growth factor 1/IGF1 receptor system (IGF1/ IGF1R) has emerged as a critical event in the transformation and tumorigenicity of a wide variety of tumor types (3) (4) (5) (6) (7) (8) (9) (10) . This type of experimentation has revealed that IGF1R is usually overexpressed in highly invasive and metastasizing tumors (2) .
The IGF1/IGF1R system has been recently studied also in carcinoid tumors (11, 12) : when these tumors arise in the gastrointestinal tract they may be characterized by hypersecretion of bioamines and neuropeptides which lead to functional tumor disease. The human BON gastrointestinal carcinoid tumor cell line has been seen to express functionally active insulin-like growth factor-1 receptors and to secrete IGF1, suggesting an autocrine action of this growth factor. Moreover, IGF1 induces a marked increase of chromogranin A secretion, a typical marker protein for neuroendocrine secretion, suggesting the existence of an autocrine IGF1 loop regulating basal neuroendocrine secretion in BON cells (11) . The activation of the raf-1/MEK1 pathway may reverse the effect of IGF1 treatment in BON cells by the depletion of intracellular chromogranin A (12) . In addition, IGF1 stimulates anchorage-dependent and anchorage-independent growth of BON cells and endogenously released IGF1 was found to be largely responsible for autonomous growth of BON cells in serum-free medium (11) . The mRNA expression of several IGF-type factors and receptors has been studied in 37 gastroenteropancreatic neuroendocrine tumors by qualitative RT-PCR showing positivity for IGF1R mRNA expression in 89% of 9 gastrinomas, 90% of 10 insulinomas, 67% of 9 carcinoid syndromes and 33% of 9 functionally inactive tumors (13) .
Interestingly, two alternatively spliced human IGF1R mRNA transcripts have been described: they differ by only three nucleotides (CAG), due to possible retaining in intron 13 of the first three bases of exon 14 (CAG), resulting in an amino-acid coding sequence change from the originally described Thr-Gly to an Arg in the extracellular portion of the receptor ß subunit (14) . IGF1R lacking CAG bases will be named IGF1R CAG -and IGF1R longest form (with CAG bases) will be named CAG + . In transfected Chinese hamster ovary (CHO) cells, the CAG -form exhibits an approximately 2-fold increase in IGF1 stimulation of several activities, in particular receptor autophosphorylation, a strict requirement for its mitogenic properties (8) , and thymidine incorporation; the slower rate of receptor internalization could cause or contribute to the increase of tyrosine phosphorylation.
To date, no data are available about the relative expression of the IGF1R CAG + /CAG -isoforms in human tumors. The aim of this work is to study for the first time the relative expression of the two IGF1R mRNA isoforms by a semiquantitative RT-PCR approach in a large series of human neuroendocrine carcinomas of different grade. We demonstrate a significantly higher expression of both isoforms in the studied tumors, as compared to normal tissue, in the presence of a constant IGF1R mRNA CAG + /CAG -rate in all studied cell types.
Materials and methods
Sample collection. Sample selection was focused on neuroendocrine tumors from multiple anatomic sites with varying differentiation grades: well-differentiated (n=10), moderatelydifferentiated (n=4), poorly-differentiated (n=10) and islet cell carcinomas (n=8). The specimens were obtained from an equal number of male and female subjects (n=16) with ages ranging between 43 and 79 years old (mean age of 63.65 years) (Table I) . Representative portions of thirty-two tumor specimens collected for the H. Lee Moffitt Cancer Center and Research Institute (Tampa, FL) Tissue Procurement Facility under institutional review board protocols were used. The resection-to-preservation (freezing) time was kept to less than 20 min. Sample storage consisted of liquid nitrogen (n=30) and -80˚C (n=2) for a mean storage period of 41.65 months. Prior to RNA isolation, twelve of these tumor samples underwent independent pathological review by a single pathologist (DC) and were macrodissected while frozen to select tumorrich areas and decrease the amount of stroma and non-neoplastic elements surrounding the target tumor tissue.
RNA sources. Total RNA from the study samples was extracted using TRIzol (Invitrogen Corp., Carlsbad, CA) following the manufacturer's protocol. The main histological features of the NE tumors are shown in Table I .
Due to the absence of tissue entirely composed of APUD (amine precursor uptake and decarboxylation) cells, which are by definition part of a diffuse system of cells, 9 commercial total RNA samples from several whole normal human organs have been used as controls: prostate (pool of 16 normal adult whole prostates), brain (one normal adult whole brain), heart (one normal adult whole heart), colon (pool of 2 normal adult colons), small intestine (pool of 2 normal adult small intestines), stomach (pool of 15 normal adult stomachs), thymus (pool of 13 normal adult thymuses), skeletal muscle (pool of 2 normal adult skeletal muscles), testis (pool of 45 normal adult testes). All RNA samples were purchased from BD Biosciences Clontech (Palo Alto, CA, USA).
RNA was quantified by both UV spectrophotometry and standard agarose gel. Quantification of electrophoresed RNA was obtained in comparison with standard markers by the gel imaging system, Gel Doc 2000 (Bio-Rad, Hercules, CA, USA).
Primer design. The primers for amplifications were designed using Amplify software (15) , following standard criteria (16) . The data source for primer design was the GenBank sequence NM_000875, Homo sapiens insulin-like growth factor 1 receptor (IGF1R), mRNA. In particular, for semiquantitative IGF1R CAG + /CAG -analysis, we designed three primers: a reverse primer common to both gene forms (#1 5'-AGCGC TGAAGTACTCCGGGTTCAC-3') and two forward primers specific for CAG + and CAG -forms, respectively. Each forward oligonucleotide was specific for only one of the two isoforms, harboring two mismatches at the last three bases of the 3' end, one being the 3'-residue, with respect to the sequence of the other isoform (#2 5'-TTCTTCTATGTCCAGGCCAAAA CAG-3' for the IGF1R CAG + form, #3 5'-TTCTTCTATGTC CAGGCCAAAAGAT-3' for the IGF1R CAG -form). The size of PCR product obtained was 189 bp with primers #1 and #2, and 186 bp with primers #1 and #3.
To amplify the B2M housekeeping gene for RNA quantity normalization, we used forward primer #4 5'-GCGGGCATT CCTGAAGCTGACAGCA-3' and reverse primer #5 5'-TAC ATCAAACATGGAGACAGCACTC-3', with an expected PCR product size of 586 bp.
RT-PCR.
For all samples, total RNA (2 μg) was reverse transcribed at 37˚C for 60 min in 50 μl of final volume by cloned Moloney murine leukemia virus reverse-transcriptase 400 U (Promega, Madison, WI; used with companion buffer), 2.5 μM oligo dT-15, 2 μM random hexamers and 500 μM each dNTP.
PCR experiments were performed in 50 μl of final volume, containing 5 μl of reverse transcription mix, 1 U of Taq Polymerase (Takara, Shiga, Japan) with companion reagents (0.2 mM each dNTP, 2 mM MgCl 2 , 1X PCR buffer), and 0.2 μM of each primer.
To uniform all PCR reactions, we performed a unique mix with PCR buffer 1X, dNTPs, MgCl 2 and Taq Polymerase. Subsequently this mix was divided into three aliquots and a different primer pair was added to each one. The cDNA samples were added after every mix was divided in single tubes. Each PCR reaction was performed in duplicate. In preliminary PCR experiments we evaluated PCR products Table I . RNA sample list. 
NE, neuroendocrine; WNH, white non-hispanic; U, unknown; M, male; F, female; HN, head and neck; Islet, Islet cell carcinoma. Percentage of tumor (not stromal) cells is given in parenthesis, when known. All tumor specimens were stored under liquid nitrogen, except NE 15 and NE 16, which were stored at -80˚C.
-
after 20, 25, 30, 35, 40 and 45 cycles (data not shown), in order to find the conditions allowing quantification of B2M, IGF1R CAG + and IGF1R CAG -RT-PCR products, respectively, at the maximum distance from the cycles corresponding to the reaction plateau.
PCR reactions were performed with high stringency: an initial denaturation step of 2 min at 94˚C was followed by amplification for 25 (B2M) or 35 (IGF1R CAG + or CAG -) cycles (30 sec at 94˚C, 30 sec at 63˚C, 45 sec at 72˚C), and a final extension for 7 min at 72˚C.
Gel imaging. Ten-μl aliquots of each PCR product were separated on 1.7% agarose TAE gels. B2M, IGF1R CAG + and IGF1R CAG -RT-PCR products from the same RNA samples were separated on the same gel. Marker M5 (Fermentas, Hanover, MD, USA) at two different dilutions was used as a quantitative reference. After separation, gels were stained in TAE buffer containing ethidium bromide (0.5 μg/ml) and detected under ultraviolet light in unsaturated pixel modality with the Gel Doc 2000 Imaging System. Digital images were quantitated and analyzed by using Quantity One software (Bio-Rad, Hercules, CA, USA).
Intensity values of the PCR product bands were calculated in comparison with a regression line with correlation coefficient ≥0.99 generated from measurements of at least four Marker M5 bands of different concentration values. In particular we used the 'Volume Rect Tool' function to acquire intensity pixel data for each band. Gel image background was always subtracted.
Statistical analysis. The mean for each replicate data point and, to normalize the IGF1R expression level, the IGF1R/B2M product mass ratio were determined. Statistical analysis was performed using StatView software. Unpaired t-test was used to compare normalized IGF1R expression levels between normal and tumoral tissues, as well as to compare the relative expression of IGF1R CAG + and CAG -isoforms. ANOVA test and Fisher's post hoc test were performed to compare IGF1R expression levels (for CAG + isoform, CAG -isoform and CAG + :CAG -ratio) in each different histological subclass of tumors (10 well-differentiated; 4 moderately differentiated; 10 poorly differentiated; 8 islet cell carcinomas; 9 normal tissues). Differences were considered significant at p<0.05.
Bioinformatic analysis. In order to study the evolution of 'subtle' splicing (17) of the IGF1R mRNA (CAG + and CAG -isoforms), we analyzed the IGF1R mRNA sequence encompassing the point alternatively spliced (GenBank #NM_000875, from base 2600 to 3000) using BLASTN software with default parameters and the following GenBank divisions: 'nr' (nonredundant), 'human ESTs' (espressed sequence tags), 'mouse ESTs' and 'other ESTs' database sequences.
Results

RT-PCR.
The RT-PCR amplification products for B2M, IGF1R CAG + and IGF1R CAG -mRNAs were successfully obtained from the 32 NE RNA samples and from 9 normal RNA controls. In all cases, gel electrophoresis analysis revealed single bands of the expected size (Fig. 1) .
Gel imaging. The gel images acquired in UV light and in 'unsaturated pixel' mode have been analyzed. RT-PCR products of B2M, IGF1R CAG + and IGF1R CAG -mRNAs obtained from the same sample were electrophoresed in the same gel.
This process generated two replicate data points, expressed as PCR product ng, which were used for subsequent elaborations.
Duplicate products for each gene were compared to evaluate the method reliability. The percentage of difference between the two replicate measurements was lower than 8% for all genes in all samples, except for IGF1R CAG -isoform values in normal samples, where the 25.26% mean difference was due to the presence of values situated near to the lowest detectable level. The mean value of the two measurements was therefore routinely used in the statistical comparisons.
Statistical analysis. The difference in B2M RT-PCR product masses (in ng) at 25 cycles of amplification was examined between the groups of tumoral and normal samples by unpaired t-test; it was not statistically significant (mean ± standard deviation: tumors, 92.85±26.23; normal tissue, 108.80±28.12).
All differences among IGF1R mRNA isoform expression levels are referred to RT-PCR product mass normalized as described in Materials and methods.
The difference in IGF1R CAG + :CAG -mRNA isoform ratio between tumors and normal tissue was not significant (mean ± standard deviation: tumors, 3.04±4.57; normal tissue, 2.82±1.06). Values for the tumor group become 2.25±0.99 if the outlier value of 27.54 CAG + :CAG -ratio is removed because it derives from the NE 16 unique neck tumor sample which gave two replicate data points at the minimum detected level in this study (mean 1.86 ng for CAG -isoform). The difference in IGF1R CAG + expression levels between tumors and normal tissue was significant (p=0.018; mean ± standard deviation: tumors, 1.17±0.66; normal tissue, 0.61±0.24), and difference of the IGF1R CAG -expression level between tumors and normal tissue was highly significant (p=0.0001; mean ± standard deviation: tumors, 0.60±0.42; normal tissue, 0.24±0.09). 1-6, 586 Bioinformatic analysis. Bioinformatic analysis was conducted by using database versions available on February 2005. In the 'nr' database, only two human mRNA sequences encompassing the variant splice point were found, both relating to the first described CAG + isoform. In the 'human ESTs' database, we identified 6 mRNA sequences related to IGF1R assignable to one of the two isoforms: 3 entries with the CAG + sequence and 3 entries with the CAG -sequence (Table II) . Fig. 2 shows the alignment of nucleotide sequences present in the GenBank database and encompassing the CAG + /CAG -exon junction. The sequence of murine IGF1R at a genomic level is not consistent with the possibility of an alternative splicing as in humans because only one CAG sequence, therefore one acceptor splice site (AG), is present at the 3' intronic boundary and the next exon begins with the CGA sequence (CAG*CGA, where * indicates the intron/exon boundary). ONCOLOGY REPORTS 15: 1249 -1256 , 2006 Table II. GenBank accession numbers of IGF1R mRNA-related sequences found by bioinformatic analysis (non-redundant and EST databases).
-----------------------------------------------------------------------------------------------------Database:
Non-redundant ESTs Isoform: CAG ---------------------------------------------------------------------------------------------- 
Equus caballus -CX596610 (articular cartilage) 
Bos taurus X54980 (kidney) CK772764 (pooled) BE752096 (pooled) AJ819671 (blood)
Ovis aries AY162434 (placenta) -
Canis familiaris XM_545828 -
Mus musculus
Rattus norvegicus
Source of tissue is given in parenthesis when known. Tca, teratocarcinoma; Pca, pancreas adenocarcinoma; ESC, embryo stem cells; PCL, pluripotent cell line; I, insulinoma.
Although the genomic sequence is not available for the IGF1R locus in other species, as Ovis aries, Bos taurus, Equus caballus and Sus scrofa, the RNA sequence corresponding to the first three bases of human exon 14 is the same (CGA), suggesting consistent intron/exon junctions among all these species.
In Callithrix jacchus, a non-anthropomorphic monkey, the RNA sequence corresponding to the first three bases of human exon 14 is CGG and, in anthropomorphic monkey Pongo pygmaeus (Orangutan) and Homo sapiens, it is CAG. In the last case, at the intron/exon junction, there are two successive splice sites separated by three bases (CAG*CAG). The Genbank numbers of all retrieved sequences are shown in Table II . Fig. 3 shows the alignment of the vertebrate IGF1R protein sequences available in GenBank (nr or EST divisions). Alignment underlines that the encoded amino acids corresponding to the CAG + /CAG -exon junction in IGF1R mRNA are conserved from rodents to humans, but they are different in fishes, amphibians and birds.
Discussion
The term 'neuroendocrine' has been used to define cells as neurons and endocrine cells that secrete their products in a regulated manner in response to a specific stimulus, and sharing a common phenotypic program characterized by the expression of specific markers, such as neuropeptides and chromogranins (18) . Various theories, such as the APUD concept, the diffuse neuroendocrine system (DNES) or the paraneuron concept, have been elaborated to classify neuroendocrine cells as a distinct and cohesive group, while it has been proposed to redefine previous 'neuroendocrine' concepts to include the notion that activation of specific genetic switches can lead to the expression of a partial or full neuroendocrine phenotype in a variety of cell types, including immune cells (18) . One type of tumor arising from neuroendocrine cells is known as carcinoid tumor. These are usually slow-growing tumors, mainly found in the gastrointestinal tract and lungs, that can be treated and often cured. However, Kulkinski (in lung) and APUD cells may also give origin to atypical carcinoids (in lung), and to moderately as well as poorly differentiated neuroendocrine tumors (small cell carcinomas). It should therefore be noted that the tumors studied are a mixture of well-differentiated carcinoids and neuroendocrine carcinomas with distinct differentiation grades. A feature of typical carcinoid tumors, except those originating in the rectum, is the cellular production of a variety of endocrine substances, mainly serotonin (5-hydroxytryptamine) and kallikrein (an activator of bradykinin release), leading to carcinoid syndrome (flushing, diarrhea, bronchoconstriction, cardiac valvular lesions, and telangiectasia) (informations in cancernet site: http://www.cancer.gov/cancerinfo/pdq/treatment/gastrointestin alcarcinoid/HealthProfessional).
Based on the proposed role of the IGF1/IGF1R system as a key regulator of mitogenesis and tumorigenicity in the growth of carcinoid tumors (11, 12) , we have studied the relative expression of IGF1R mRNA splicing isoforms CAG + and CAG -in a large series of human neuroendocrine tumors; CAG -CHO cells were previously described to have a 2-fold stronger induction of activities related to mitogenesis with respect to CAG + in a transfection model (14) . We employed an original semiquantitative RT-PCR approach to measure the different expression levels of the two IGF1R mRNA isoforms in human samples. Our method is mainly based on duplicated reactions for each sample in highly standardized conditions (2.0 μg of starting RNA, large-scale PCR experiments with the same reagent mix) followed by accurate digital measurement of amplification product mass at a cycle distant from PCR plateau attainment. The reliability of the test was confirmed by the following: the absence of differences between tumoral and normal samples in B2M expression level, suggesting that comparable expression of the reference house-keeping gene B2M may be assumed in the two groups; good consistency among replicate experiments performed for each sample; and excellent precision in RT-PCR product mass measurement via gel imaging allowed by linear regression based on at least four known marker points with a correlation coefficient ≥0.99.
Data about the expression levels of IGF1R in 32 RNA samples from neuroendocrine human tumors of different grade as well as in 9 normal tissues were produced by this method. We found IGF1R mRNA expression in 100% of our samples, in constrast with data from the series described by Wulbrand et al (13) , who reported IGF1R mRNA expression in 67-90% of samples from comparable tumor types.
The first main finding is that neuroendocrine tumor cells express IGF1R CAG + mRNA at a significantly higher level than normal tissue cells, with a consistent 2-fold mean increase. The IGF1R CAG -isoform RNA was also expressed at a significantly higher level in tumoral cells than in normal cells, although its amount was lower than the CAG + isoform. It is worth noting that the CAG -form has been demonstrated to elicit mitogenic activities with a double intensity than the CAG + isoform. These data highlight a role for IGF1/IGF1R system in neuroendocrine tumor cells biology.
The second main finding is that, when considering the CAG + :CAG -ratio of the IGF1R isoforms in tumoral and normal cells, an approximate 3:1 ratio was found in both cell types. This finding suggests that the biology of neuroendocrine tumor cells, while showing an increase in IGF1R mRNA level, still stringently maintains the same IGF1R CAG + :CAG -ratio present in normal tissue, suggesting that this ratio may be tightly regulated in both normal and neoplastic cells. This reinforces the notion that 'subtle' splicing (17) , a novel concept of alternative splicing leading to mRNA isoforms different by only three bases, is a non-random method of RNA splicing regulation, and that this type of splicing may lead to the regulated production of protein isoforms different by one amino acid.
In addition, while a previous study has demonstrated higher activity in the signal transduction of the transfected and overexpressed IGF1R CAG -pure mRNA isoform (14) , our measurement of the naturally occurring expression ratio of both CAG + and CAG -mRNA isoforms lead to the prediction that, if the relative aliquot of CAG + and CAG -derived receptor chains is proportional to mRNA and if the dimerization of these two protein types is allowed, the IGF1R dimerized receptor could be of three types: CAG + /CAG + , CAG + /CAG -or CAG -/CAG -. The proportions of these types depend on the probability of association due to the relative frequency of each form.
Finally, we present a phylogenetic analysis to assess the evolution of this particular type of splicing in the species whose sequence data were available. In the region corresponding to the CAG + /CAG -alternative splicing site of the human IGF1R receptor, a nucleotide change in the rat eliminates the alternative acceptor splice site (19) ; analysis at RNA level also rules out the possibility to give rise to IGF1R CAG + /CAG -isoforms for Ovis aries, Bos taurus, Equus caballus and Sus scrofa mammalian species. Only in humans and in the anthropomorphic monkey, Pongo pygmaeus, did the physical base for a 'subtle' alternative splicing appear, via the creation of two successive splice sites separated for three bases (CAG*CAG) at the boundary of IGF1R locus intron 13/exon 14. The phylogenetic study of this locus may explain why human IGF1R CAG + mRNA isoform is prevalent on the CAG -isoform, because the second splice site leading to the CAG -isoform is more recent from an evolutionary point of view and it could be used by the splicing apparatus at this intron/exon junction with a lower efficiency than the previous conserved site. Interestingly, while the IGF1R proteins share a very similar sequence from fishes to humans, the encoded amino acids corresponding to the CAG + /CAG -exon junction in the IGF1R mRNA are conserved from rodents to humans, but they are different in fishes, amphibians and birds. Further studies are needed to explore the fine regulation and consequences for cell growth and biology of the presence of different IGF1R mRNA isoforms leading to receptor variants different by one amino acid ('subtle' alternative splicing).
In conclusion, this work highlights the relevance of 'subtle' alternative splicing for the IGF1R locus, showing overexpression of both mRNA isoforms in a large series of ONCOLOGY REPORTS 15: 1249 -1256 , 2006 human neuroendocrine tumors in the presence of a constant relative expression of the two isoforms.
